Information Provided By: 
Fly News Breaks for February 5, 2016
CERS
Feb 5, 2016 | 07:53 EDT
Stephens analyst Drew Jones noted that the first cases of Zika virus infection caused by blood transfusion have been reported in Brazil and stated that he believes Cerus has the most reliable method to defend blood supplies against emerging pathogens like Zika. Jones, who thinks the threat of emerging pathogens could result in incremental market penetration for Cerus, reiterates an Overweight rating and $9 price target on the stock.
News For CERS From the Last 2 Days
There are no results for your query CERS
